Comparison of Biologicals in Treatment of Severe Asthma

NCT04158050 · clinicaltrials.gov ↗

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: IL5 Antagonist or anti-IL5R-antibody or Omalizumab

Sponsor

Helsinki University Central Hospital

Collaborators

[object Object]